DEBRA WILKS: Open Payments
NPI 1801429451 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,366 in 147 payments from 16 companies in 2025. Trend: 2023 $1,125 · 2024 $1,939 · 2025 $2,366
Food & beverage: $2,366
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 67 | $990 |
| Biogen, Inc. | 19 | $349 |
| PFIZER INC. | 20 | $205 |
| Novartis Pharmaceuticals Corporation | 9 | $186 |
| Neurocrine BioSciences, Inc. | 9 | $156 |
| ARGENX US, INC. | 6 | $146 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| Lundbeck LLC | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| UCB, Inc. | 2 | $42 |
Products named: QULIPTA, UBRELVY, NURTEC ODT, KESIMPTA, TYSABRI, INGREZZA, VYVGART HYTRULO, LEQEMBI.
Industry payments across KY — which companies pay providers there.
